ATOSSA THERAPEUTICS INC (ATOS)
US04962H5063 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 88.46M | 110.90M | 136.40M | 39.60M | 12.60M | |||
| Receivables | 0.00 | 700.00K | 1.10M | 600.00K | 700.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 3.76M | 6.50M | 3.80M | 2.60M | 1.00M | |||
| Total Current Assets | 92.22M | 118.20M | 141.20M | 42.80M | 14.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 0.00 | 0.00 | 100.00K | |||
| Investments And Advances | 1.71M | 4.70M | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | 0.00 | 0.00 | 100.00K | |||
| Other Non-Current Assets | 2.32M | 600.00K | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Assets | 4.03M | 5.30M | 100.00K | 0.00 | 200.00K | |||
| TOTAL ASSETS | 96.25M | 123.50M | 141.30M | 42.80M | 14.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.63M | 2.60M | 1.40M | 1.10M | 1.00M | |||
| Accounts Payable | 806.00K | 3.00M | 1.70M | 1.60M | 300.00K | |||
| Other Current Liabilities | 1.80M | 0.00 | 0.00 | 13.00M | 0.00 | |||
| Total Current Liabilities | 5.24M | 5.60M | 3.10M | 15.70M | 1.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 5.24M | 5.60M | 3.10M | 15.70M | 1.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -186.29M | -156.20M | -129.20M | -111.90M | -94.10M | |||
| Additional Paid In Capital | 255.99M | 250.80M | 244.00M | 129.90M | 104.90M | |||
| Common Shares | 22.79M | 23.40M | 23.40M | 9.20M | 2.30M | |||
| Treasury Stock | -1.48M | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 125.30M | 126.60M | 126.60M | 47.50M | 9.10M | |||
| Tangible Book Value per Share | 0.73 | 0.93 | 1.09 | 0.56 | 1.36 | |||
| Total Shareholders' Equity | 91.02M | 118.00M | 138.10M | 27.20M | 13.20M | |||
| TOTAL LIABILITIES AND EQUITY | 96.25M | 123.50M | 141.30M | 42.80M | 14.50M | |||
| Statistics | ||||||||
| Current Ratio | 17.61 | 21.11 | 45.55 | 2.73 | 11.00 | |||
| Return On Assets (ROA) | -31.27% | -21.83% | -14.59% | -52.17% | -118.90% | |||
| Return On Equity (ROE) | -33.06% | -22.85% | -14.92% | -82.10% | -130.61% | |||
All data in USD